[go: up one dir, main page]

DK0804219T3 - Inhibinpræparater og fremgangsmåder til anvendelse deraf - Google Patents

Inhibinpræparater og fremgangsmåder til anvendelse deraf

Info

Publication number
DK0804219T3
DK0804219T3 DK95913576T DK95913576T DK0804219T3 DK 0804219 T3 DK0804219 T3 DK 0804219T3 DK 95913576 T DK95913576 T DK 95913576T DK 95913576 T DK95913576 T DK 95913576T DK 0804219 T3 DK0804219 T3 DK 0804219T3
Authority
DK
Denmark
Prior art keywords
protein
heterologous protein
inhibin
heterologous
fused
Prior art date
Application number
DK95913576T
Other languages
English (en)
Inventor
William C Fioretti
Konstantin Kousoulas
Daniel G Satterlee
Original Assignee
Agritech Technologies Ltd
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agritech Technologies Ltd, Univ Louisiana State filed Critical Agritech Technologies Ltd
Application granted granted Critical
Publication of DK0804219T3 publication Critical patent/DK0804219T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
DK95913576T 1994-02-28 1995-02-28 Inhibinpræparater og fremgangsmåder til anvendelse deraf DK0804219T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20296494A 1994-02-28 1994-02-28
PCT/US1995/002795 WO1995022980A1 (en) 1994-02-28 1995-02-28 Inhibin compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
DK0804219T3 true DK0804219T3 (da) 2002-11-11

Family

ID=22751927

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913576T DK0804219T3 (da) 1994-02-28 1995-02-28 Inhibinpræparater og fremgangsmåder til anvendelse deraf

Country Status (18)

Country Link
EP (1) EP0804219B1 (da)
JP (1) JPH09510702A (da)
CN (1) CN1149258A (da)
AT (1) ATE220554T1 (da)
AU (1) AU704737B2 (da)
BR (1) BR9507426A (da)
CA (1) CA2184183C (da)
DE (1) DE69527439T2 (da)
DK (1) DK0804219T3 (da)
ES (1) ES2181771T3 (da)
FI (1) FI963325A7 (da)
MX (1) MX9603702A (da)
NO (1) NO963572L (da)
NZ (1) NZ282981A (da)
PL (1) PL184202B1 (da)
PT (1) PT804219E (da)
RU (1) RU2170100C2 (da)
WO (1) WO1995022980A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747659A (en) * 1994-02-28 1998-05-05 Agritech Technologies, Ltd. Fusion gene products encoding avian alpha subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein
US5786179A (en) * 1994-02-28 1998-07-28 Agritech Technologies Ltd. Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same
EP1567542A4 (en) * 2002-11-07 2006-12-27 Agritech Technology Ltd NEW MULTI-TENANT PEPTIDE COMPOSITIONS RELATED TO INHIBINE INCREASING THE PRODUCTION PERFORMANCE OF BIRDS
SI3308788T1 (sl) 2005-06-23 2019-01-31 Biogen Ma Inc. Sestave in metode za modulacijo združevanja SMN2
WO2007026689A1 (ja) * 2005-08-29 2007-03-08 Japan Science And Technology Agency ダチョウを用いた抗体、及びその作製方法
EP2442816A4 (en) 2009-06-17 2013-10-02 Isis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR MODULATING SMN2 DISTRIBUTION IN THE BODY OF A PATIENT
US9926559B2 (en) 2013-01-09 2018-03-27 Biogen Ma Inc. Compositions and methods for modulation of SMN2 splicing in a subject
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
MA39835A (fr) 2014-04-17 2017-02-22 Biogen Ma Inc Compositions et procédés de modulation de l'épissage du smn2 chez un patient
US10436802B2 (en) 2014-09-12 2019-10-08 Biogen Ma Inc. Methods for treating spinal muscular atrophy
WO2017218884A1 (en) 2016-06-16 2017-12-21 Ionis Pharmaceuticals, Inc. Combinations for the modulation of smn expression
CN110551744A (zh) * 2019-09-18 2019-12-10 普健生物（武汉）科技有限公司 一种人抑制素a的核苷酸序列及重组表达人抑制素a的方法
JOP20220201A1 (ar) 2020-02-28 2023-01-30 Ionis Pharmaceuticals Inc مركبات وطرق لتعديل smn2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom

Also Published As

Publication number Publication date
RU2170100C2 (ru) 2001-07-10
MX9603702A (es) 1997-12-31
DE69527439T2 (de) 2003-02-20
FI963325A0 (fi) 1996-08-27
FI963325L (fi) 1996-10-21
EP0804219A4 (en) 1999-02-24
NO963572L (no) 1996-10-25
FI963325A7 (fi) 1996-10-21
EP0804219A1 (en) 1997-11-05
BR9507426A (pt) 1997-09-16
PL184202B1 (pl) 2002-09-30
DE69527439D1 (de) 2002-08-22
CA2184183A1 (en) 1995-08-31
EP0804219B1 (en) 2002-07-17
NZ282981A (en) 1998-08-26
ATE220554T1 (de) 2002-08-15
CA2184183C (en) 2005-02-08
PL316628A1 (en) 1997-02-03
CN1149258A (zh) 1997-05-07
AU2095995A (en) 1995-09-11
JPH09510702A (ja) 1997-10-28
NO963572D0 (no) 1996-08-27
WO1995022980A1 (en) 1995-08-31
ES2181771T3 (es) 2003-03-01
PT804219E (pt) 2002-12-31
AU704737B2 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
DK0804219T3 (da) Inhibinpræparater og fremgangsmåder til anvendelse deraf
Price et al. Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone
Solari et al. Biosynthesis of the IgA antibody receptor: a model for the transepithelial sorting of a membrane glycoprotein
IT1203672B (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
GB2283020B (en) Clostridium perfringens vaccines
ATE262348T1 (de) Mittel zur verabreichung von antigenen
DE69331758D1 (de) Fibrinogen-bildungsprotein
ATE235250T1 (de) Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung
BR9809656A (pt) Composição imunopotencializante
Bal et al. Formation of the extracellular mucous matrix of olfactory neuroepithelium: identification of partially glycosylated and nonglycosylated precursors of olfactomedin
DK0994721T3 (da) Nervevækstfaktor som vaccineadjuvans
BR9713847A (pt) Polipeptìdeo isolado codificado por um gene semelhante a lipase, composição, composição farmacêutica, fragmento antigênico, ácido nucleico isolado, vetor, célula recombinante, anticorpo, célula de hibridoma, processos para preparar um polipeptìdeo, para triar agonistas ou antagonistas de atividade llg, para a hidrólise enzimática de um éster de fosfatidilcolina, e para melhorar o perfil de lipìdeo no soro de um humano ou outro animal tendo um perfil de lipìdeo indesejável, e, camundongo transgênico.
Cencič et al. The porcine trophoblastic interferon‐γ, secreted by a polarized epithelium, has specific structural and biochemical properties
ATE141283T1 (de) Verfahren zur reinigung eines hochglykosylierten proteins
Yakulis et al. Production of Fe fragments of IgM
KR940005665A (ko) 분리된 폴리펩티드, 이를 암호하는 핵산 분자, 상기 폴리펩티드를 포함하는 조성물 및 이를 사용하는 방법
AU633967B2 (en) Cleavage promoter
DE69426303D1 (de) Verfahren zur unterdrückung der immunantwort durch gentherapie
DE60141938D1 (de) Verfahren zur vorbeugung und linderung angiogener erkrankungen durch impfung mit dem rezeptor für gbs-toxin (cm101)
TW202530404A (zh) 具有人ＩｇＧ截切活性之多肽
Pierre et al. Mouse secretory component
Mezzano et al. ANTIBODY-PRODUCTION AND ANTIGENIC SPECIFIC SUPPRESSION TO BOVINE SERUM-ALBUMIN IN UREMIC RATS
Trenkle et al. Studies on pituitary lactogenic hormone. XXI. Immunochemical studies of the sheep hormone
Karkhanis et al. Antigenic subunit of the polypeptide antigenic complex of the Melvin strain of Neisseria gonorrhoeae
Delaunay et al. Immunogenic properties of eukaryotic ribosomal proteins